Focus on mast cells in the tumor microenvironment: Current knowledge and future directions

Biochim Biophys Acta Rev Cancer. 2023 Jan;1878(1):188845. doi: 10.1016/j.bbcan.2022.188845. Epub 2022 Dec 5.

Abstract

Mast cells (MCs) are crucial cells participating in both innate and adaptive immune processes that play important roles in protecting human health and in the pathophysiology of various diseases, such as allergies, cardiovascular diseases, and autoimmune diseases. In the context of tumors, MCs are a non-negligible population of immune cells in the tumor microenvironment (TME). In most tumor types, MCs accumulate in both the tumor tissue and the surrounding tissue. MCs interact with multiple components of the TME, affecting TME remodeling and the tumor cell fate. However, controversy persists regarding whether MCs contribute to tumor progression or trigger an anti-tumor immune response. This review focuses on the context of the TME to explore the specific properties and functions of MCs and discusses the crosstalk that occurs between MCs and other components of the TME, which affect tumor angiogenesis and lymphangiogenesis, invasion and metastasis, and tumor immunity through different mechanisms. We also anticipate the potential role of MCs in cancer immunotherapy, which might expand upon the success achieved with existing cancer therapies.

Keywords: Cancer immunotherapy; Mast cell; Tumor microenvironment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Immunity
  • Immunotherapy
  • Mast Cells* / pathology
  • Neoplasms* / pathology
  • Neovascularization, Pathologic / pathology
  • Tumor Microenvironment